
CH:SBIO
Invesco NASDAQ Biotech UCITS ETF
Invesco NASDAQ Biotech UCITS ETF (CH:SBIO) Price & Chart
CH:SBIO ETF Chart & Stats
No data to display
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- AUM
- N/A
- NAV
- N/A
- Expense Ratio
- N/A
- Holdings Count
- 268
- Beta
- N/A
- Inception Date
- Nov 07, 2014
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- N/A
- Standard Deviation
- N/A
ETF Overview
Invesco NASDAQ Biotech UCITS ETF
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index) 1, less fees, expenses and transaction costs.
- Asset Class
- Equity
- Region
- North America
- Issuer
- Invesco
- Index Tracked
- NASDAQ / Biotechnology
- Ticker Symbol
- CH:SBIO
CH:SBIO ETF News





Regeneron Updates Obesity Drug Study as Investors Await Results
Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals (NASDAQ: REGN) updated its Phase 2 study, officially titled “A Randomized, Double-Blind Study of The
4d agoREGN
CH:SBIO ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate BuyAverage Price Target: 97.50Blogger Sentiment
NeutralLearn more about TipRanks Smart Score








